Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-258.36M 88.13M 14.46B
Depreciation & Amortization
144.75M 156.6M 86.83M
Stock-Based Compensation
n/a n/a 7.74M
Other Working Capital
103.09M -1.33B 784.17M
Other Non-Cash Items
-134.6M -760K 73.35M
Deferred Income Tax
76.32M -83.01M 265.1M
Change in Working Capital
277.91M -1.08B 460.62M
Operating Cash Flow
106.02M -770.75M 15.35B
Capital Expenditures
-145.69M -403.37M -719.98M
Cash Acquisitions
39K 8.92M -13.66M
Purchase of Investments
-8.36B -11.66B -8.83B
Sales Maturities Of Investments
5.58B 6.33B 6.57B
Other Investing Acitivies
n/a -35.08M -30.81M
Investing Cash Flow
-2.93B -5.76B -3.02B
Debt Repayment
238.84M -4.32M -26.14M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
-328.08M -263.17M -1.88B
Other Financial Acitivies
12.5M 26.09M 4.32M
Financial Cash Flow
-76.06M -241.4M -1.9B
Net Cash Flow
-3.01B -7.33B 10.57B
Free Cash Flow
-41.69M -1.17B 14.63B